Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers (clinicaltrials.gov) - Oct 10, 2023 - P=N/A | N=24 | Completed | Sponsor: Valenta Pharm JSC | Recruiting ➔ Completed | Trial completion date: Dec 2023 ➔ Dec 2022 | Trial primary completion date: Dec 2023 ➔ Nov 2022
Trial completion • Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases
|